[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-cancer-research-uk-drug-development-project-2026":3,"similar-cancer-research-uk-drug-development-project-2026":31},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":9,"duration":8,"trl":10,"relevance":8,"why_relevant":8,"early_career":11,"consortium":12,"first_seen":13,"last_updated":8,"update_note":8,"status":14,"stages":15,"call_frequency":16,"next_call_expected":8,"source_url":7,"created_at":17,"updated_at":18,"eligible_countries":19,"description":21,"seo_summary":22,"recurring_round":11,"canonical_id":4,"links":23},"cancer-research-uk-drug-development-project-2026","Drug Development Project","Cancer Research UK","https:\u002F\u002Fwww.cancerresearchuk.org\u002Ffor-researchers\u002Fapply-for-and-manage-your-funding\u002Four-funding-schemes\u002Fdrug-development-project",null,"Rolling deadline","3-6",false,"No - individual applicant based at academic institution or pharma\u002Fbiotech company, project run in partnership with CRUK's Centre for Drug Development","2026-09-06T00:00:00.000Z","open","Informal confidential discussion, then formal review by New Agents Committee (up to 4 times per year)","Continuous","2026-09-06T15:53:40.937Z","2026-09-07T09:38:25.912Z",[20],"GB","Supports preclinical development through early phase (Phase 1\u002Fearly Phase 2) clinical trials of novel cancer agents; not external grant funding but scientific, clinical and trial management resources provided by CRUK's Centre for Drug Development. Open to academic institutions and pharma\u002Fbiotech companies (UK or international); requires prior confidential discussion and eligibility check.","{\"faq\":[{\"q\":\"How much funding does the CRUK Drug Development Project provide?\",\"a\":\"It is not a cash grant; instead CRUK's Centre for Drug Development provides scientific, clinical and trial management resources to progress the project.\"},{\"q\":\"Who can apply for the CRUK Drug Development Project?\",\"a\":\"Individual applicants (no consortium required) based at an academic institution or a pharma\u002Fbiotech company, either in the UK or internationally.\"},{\"q\":\"What stage of drug development does this scheme support?\",\"a\":\"It covers preclinical development through early phase clinical trials, corresponding to TRL 3-6, up to Phase 1 or early Phase 2.\"},{\"q\":\"When is the deadline for the CRUK Drug Development Project?\",\"a\":\"There is no fixed deadline; applications are accepted on a rolling basis and reviewed by the New Agents Committee up to four times a year.\"},{\"q\":\"Do I need a consortium to apply?\",\"a\":\"No, this call does not require a consortium; the project runs as a partnership between the individual applicant and CRUK's Centre for Drug Development.\"}],\"key_dates\":[\"Rolling deadline; applications accepted continuously\",\"Two-stage process: informal confidential discussion first, then formal review by the New Agents Committee (up to 4 times per year)\"],\"meta_description\":\"CRUK Drug Development Project offers resources (not cash) for preclinical to early-phase clinical cancer drug projects, from Cancer Research UK.\",\"summary\":\"The Drug Development Project channels scientific, clinical and trial management resources from Cancer Research UK's Centre for Drug Development into preclinical through early-phase (Phase 1\u002Fearly Phase 2) clinical development of novel cancer agents. It is open to individual applicants at academic institutions or pharma\u002Fbiotech companies, in the UK or internationally, and runs as a direct partnership rather than a traditional grant. Applications are accepted continuously, starting with an informal confidential discussion before formal review.\",\"tags\":[\"oncology\",\"drug-development\",\"cancer-research-uk\",\"translational-research\",\"clinical-trials\",\"industry-partnership\",\"preclinical\",\"rolling-deadline\"],\"tips\":[\"Request the informal confidential discussion early, it determines eligibility before you commit to a formal submission.\",\"Frame the project around TRL 3-6 milestones; the New Agents Committee assesses readiness for preclinical-to-clinical progression specifically.\",\"Since this provides in-kind resources rather than a grant, emphasize what CRUK's Centre for Drug Development capabilities (not your own budget) can add to the project.\"],\"who_should_apply\":[\"Researchers or teams with a novel cancer agent ready for preclinical to early clinical development\",\"Applicants based at academic institutions, UK or international\",\"Applicants based at pharma or biotech companies, UK or international\",\"Projects at TRL 3-6, targeting Phase 1 or early Phase 2 trials\",\"Individual applicants who do not need a pre-formed consortium\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":24,"countryHubs":25,"domainHubs":29,"closingMonth":8,"hasRelated":11,"hasBrowseRelated":30},[],[26],{"slug":27,"demonym":28},"gb","UK researchers",[],true,{"grants":32},[33,38,43,47,51],{"id":34,"name":35,"funder":36,"deadline":8,"budget":37},"kwf-cdd-scouting-programme-2026","CDD Scouting Programme","KWF","Up to €2 million per project",{"id":39,"name":40,"funder":6,"deadline":41,"budget":42},"cancer-research-uk-therapeutic-catalyst-early-therapy-award-2026-09","Therapeutic Catalyst - Early Therapy Award","2026-09-25T00:00:00.000Z","Up to £350k",{"id":44,"name":45,"funder":6,"deadline":41,"budget":46},"cancer-research-uk-therapeutic-catalyst-2026-09","Therapeutic Catalyst","Up to £250k (Target Award) or up to £350k (Early Therapy Award)",{"id":48,"name":49,"funder":6,"deadline":8,"budget":50},"cancer-research-uk-childhood-cancer-therapeutic-catalyst-2026","Childhood Cancer Therapeutic Catalyst","Up to £250k",{"id":52,"name":53,"funder":6,"deadline":54,"budget":55},"cancer-research-uk-discovery-programme-award-2026-09","Discovery Programme Award","2026-09-29T00:00:00.000Z","Up to £2.5m"]